Institutional investors purchased a net $7.8 million shares of GSK during the quarter ended March 2016 and now own 8.60% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CIBC WORLD MARKETS, INC. Bought 102.5 Thousand shares of GlaxoSmithKline
FISHER ASSET MANAGEMENT LLC Bought 73.0 Thousand shares of GlaxoSmithKline
LPL FINANCIAL LLC Bought 59.9 Thousand shares of GlaxoSmithKline